Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19

Name: Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19
License: Public Domain

Shanghai Zerun Biotechnology Co.,Ltd

ClinicalTrials.gov · Datasets · License: Public Domain

covid-19

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 143660
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.